NASDAQ:FDMT

4d Molecular Therapeutics Stock Forecast

etoro logo Buy FDMT
*Your capital is at risk
$8.84
+0.115 (+1.32%)
At Close: Jun 11, 2026
AI Analysis AI Analysis of FDMT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add FDMT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

4D Molecular Therapeutics, Inc. stock price ended at $8.84 on Thursday, after gaining 1.32%
(Updated on Jun 11, 2026)

Sell candidate since Jun 05, 2026 Gain 2.26%

The 4D Molecular Therapeutics, Inc. stock price gained 1.32% on the last trading day (Thursday, 11th Jun 2026), rising from $8.72 to $8.84. During the last trading day the stock fluctuated 6.03% from a day low at $8.37 to a day high of $8.88. The price has risen in 5 of the last 10 days but is still down by -1.51% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 67 thousand more shares were traded than the day before. In total, 680 thousand shares were bought and sold for approximately $6.01 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect 4D Molecular Therapeutics, Inc. stock with a 90% probability to be traded between $8.31 and $10.71 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

FDMT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The 4D Molecular Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.09 and $9.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -11.74%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for 4D Molecular Therapeutics, Inc. stock

4D Molecular Therapeutics, Inc. finds support from accumulated volume at $8.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.505 between high and low, or 6.03%. For the last week, the stock has had daily average volatility of 8.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FDMT) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect 4D Molecular Therapeutics, Inc. to open at $8.69, and during the day (based on 14 day Average True Range), to move between $8.50 and $9.17, which gives a possible trading interval of +/-$0.672 (+/-7.91%) up or down from last closing price. If 4D Molecular Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.64 (2.21%) than the resistance at $9.71 (9.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is 4D Molecular Therapeutics, Inc. stock A Buy?

4D Molecular Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.226 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $8.69 ( 1.60%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

FDMT Performance

Trading levels for FDMT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.20 4.11%
R2 9.01 1.93%
R1 8.89 0.580%
Price 8.84
S1 8.50 -3.79%
S2 8.38 -5.14%
S3 8.19 -7.32%

Accumulated Volume Support & Resistance Levels

Level Price
R3 10.18 15.22%
R2 9.91 12.17%
R1 9.71 9.90%
Price 8.84
S1 8.64 -2.21%
S2 8.61 -2.55%
S3 8.57 -3.00%

FAQ

What is the symbol for 4D Molecular Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for 4D Molecular Therapeutics, Inc. is FDMT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell 4D Molecular Therapeutics, Inc. Stock?
4D Molecular Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy 4D Molecular Therapeutics, Inc. Stock?
4D Molecular Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy 4D Molecular Therapeutics, Inc. Stock.

What's the current price of 4D Molecular Therapeutics, Inc. Stock?
As of the end of day on the Jun 11, 2026, the price of an 4D Molecular Therapeutics, Inc. (FDMT) share was $8.84.

What is the 52-week high and low for 4D Molecular Therapeutics, Inc. Stock?
The 52-week high for 4D Molecular Therapeutics, Inc. Stock is $12.34 and the 52-week low is $3.68.

What is the market capitalization of 4D Molecular Therapeutics, Inc. Stock?
As of the Jun 11, 2026, the market capitalization of 4D Molecular Therapeutics, Inc. is 461.861M.

When is the next earnings date for 4D Molecular Therapeutics, Inc.?
The upcoming earnings date for 4D Molecular Therapeutics, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT 4D MOLECULAR THERAPEUTICS, INC.
4D Molecular Therapeutics
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; ...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE